Greenbrook TMS to Host Investor Webcast on June 7, 2022

Rhea-AI Summary

Greenbrook TMS Inc. (TSX: GTMS) will hold a webcast investor presentation on June 7, 2022, at 2:00 PM ET. CEO Bill Leonard will present key insights about the company's operations, followed by a Q&A session for investors. Pre-registration is required to participate in the webcast, which can be done through the provided link. An archived version will also be accessible on Greenbrook's website after the event. Greenbrook is a prominent provider of Transcranial Magnetic Stimulation therapy, having administered over 840,000 treatments to more than 24,000 patients across the U.S.

TORONTO--(BUSINESS WIRE)-- Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) is pleased to announce that it will host a webcast investor presentation on Tuesday, June 7th, 2022, at 2:00 PM ET.

During the webcast, Bill Leonard, Chief Executive Officer, will conduct a presentation that will cover key areas of Greenbrook’s business. After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A portal.

To listen to the webcast or to ask questions during the live event, please pre-register at the following link: https://event.webcasts.com/starthere.jsp?ei=1545464&tp_key=65f37425dc.

An archived version of the webcast and presentation will be available on the Company’s website, https://www.greenbrooktms.com/investors/events.htm following the event.

About Greenbrook TMS Inc.

Operating through 148 Company-operated treatment centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 840,000 TMS treatments to over 24,000 patients struggling with depression.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220601005343/en/

Glen Akselrod

Investor Relations

Greenbrook TMS Inc.

Contact Information:

investorrelations@greenbrooktms.com

1-855-797-4867

Source: Greenbrook TMS Inc.

FAQ

When is the Greenbrook TMS investor presentation scheduled?

The Greenbrook TMS investor presentation is scheduled for June 7, 2022, at 2:00 PM ET.

Who will present during the Greenbrook TMS webcast?

CEO Bill Leonard will present during the Greenbrook TMS webcast.

How can investors participate in the Greenbrook TMS webcast?

Investors can participate in the Greenbrook TMS webcast by pre-registering through the provided link.

Will the Greenbrook TMS webcast be available later?

Yes, an archived version of the Greenbrook TMS webcast will be available on their website after the event.

What services does Greenbrook TMS offer?

Greenbrook TMS offers Transcranial Magnetic Stimulation therapy for treating Major Depressive Disorder and other mental health disorders.

How many TMS treatments has Greenbrook provided?

Greenbrook has provided over 840,000 TMS treatments to more than 24,000 patients.